138 related articles for article (PubMed ID: 16529415)
1. Controlled delivery of antisense oligodeoxynucleotide from cationically modified phosphorylcholine polymer films.
Zhang Z; Cao X; Zhao X; Withers SB; Holt CM; Lewis AL; Lu JR
Biomacromolecules; 2006 Mar; 7(3):784-91. PubMed ID: 16529415
[TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of anti-sense oligodeoxynucleotide from multilayered biocompatible phosphorylcholine polymer films.
Zhang Z; Cao X; Zhao X; Holt CM; Lewis AL; Lu JR
J Control Release; 2008 Aug; 130(1):69-76. PubMed ID: 18562037
[TBL] [Abstract][Full Text] [Related]
3. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
Lewis KJ; Irwin WJ; Akhtar S
J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
[TBL] [Abstract][Full Text] [Related]
4. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
5. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
[TBL] [Abstract][Full Text] [Related]
6. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
Ginobbi P; Geiser TA; Ombres D; Citro G
Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
[TBL] [Abstract][Full Text] [Related]
8. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide structure influences the interactions between cationic polymers and oligonucleotides.
Sundaram S; Viriyayuthakorn S; Roth CM
Biomacromolecules; 2005; 6(6):2961-8. PubMed ID: 16283715
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation and drug delivery application of cationically modified phospholipid polymers.
Palmer RR; Lewis AL; Kirkwood LC; Rose SF; Lloyd AW; Vick TA; Stratford PW
Biomaterials; 2004 Aug; 25(19):4785-96. PubMed ID: 15120525
[TBL] [Abstract][Full Text] [Related]
11. Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.
Junghans M; Loitsch SM; Steiniger SC; Kreuter J; Zimmer A
Eur J Pharm Biopharm; 2005 Jul; 60(2):287-94. PubMed ID: 15939239
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligodeoxynucleotide complexation with phosphoryl-choline diblock copolymers and its effect on cell transfection.
Sun T; Zhang Z; Cao X; Zhang M; Zhao X; Zhang Q; Chen M
J Control Release; 2011 Nov; 152 Suppl 1():e172-3. PubMed ID: 22195831
[No Abstract] [Full Text] [Related]
13. Group reorientation and migration of amphiphilic polymer bearing phosphorylcholine functionalities on surface of cellular membrane mimicking coating.
Yang S; Zhang SP; Winnik FM; Mwale F; Gong YK
J Biomed Mater Res A; 2008 Mar; 84(3):837-41. PubMed ID: 17635030
[TBL] [Abstract][Full Text] [Related]
14. Nanostructure of polyplexes formed between cationic diblock copolymer and antisense oligodeoxynucleotide and its influence on cell transfection efficiency.
Zhao X; Pan F; Zhang Z; Grant C; Ma Y; Armes SP; Tang Y; Lewis AL; Waigh T; Lu JR
Biomacromolecules; 2007 Nov; 8(11):3493-502. PubMed ID: 17939715
[TBL] [Abstract][Full Text] [Related]
15. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides.
Kim SH; Kim EJ; Hou JH; Kim JM; Choi HG; Shim CK; Oh YK
Biomaterials; 2009 Feb; 30(5):959-67. PubMed ID: 19027156
[TBL] [Abstract][Full Text] [Related]
16. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
[TBL] [Abstract][Full Text] [Related]
17. Effective intracellular delivery of oligonucleotides in order to make sense of antisense.
Shi F; Hoekstra D
J Control Release; 2004 Jun; 97(2):189-209. PubMed ID: 15196747
[TBL] [Abstract][Full Text] [Related]
18. Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides.
Zhu SG; Xiang JJ; Li XL; Shen SR; Lu HB; Zhou J; Xiong W; Zhang BC; Nie XM; Zhou M; Tang K; Li GY
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):179-87. PubMed ID: 15032738
[TBL] [Abstract][Full Text] [Related]
19. Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle.
Lesh RE; Somlyo AP; Owens GK; Somlyo AV
Circ Res; 1995 Aug; 77(2):220-30. PubMed ID: 7614709
[TBL] [Abstract][Full Text] [Related]
20. Biological responses to cationically charged phosphorylcholine-based materials in vitro.
Rose SF; Lewis AL; Hanlon GW; Lloyd AW
Biomaterials; 2004 Sep; 25(21):5125-35. PubMed ID: 15109836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
